A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome
Clinical trial NCT04993989 · COMPLETED
Trial details
- NCT number
- NCT04993989
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-16
- Primary completion
- 2018-04-18
- Enrollment
- 843
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.